Anti-IDH1 (Hu) from Rat (W09)
Artikelnummer:
DNA-DIA-W09
- Bilder (4)
| Artikelname: | Anti-IDH1 (Hu) from Rat (W09) |
| Artikelnummer: | DNA-DIA-W09 |
| Hersteller Artikelnummer: | DNA-DIA-W09 |
| Alternativnummer: | DNA-DIA-W09 |
| Hersteller: | dianova |
| Wirt: | Rat |
| Kategorie: | Antikörper |
| Applikation: | IHC |
| Spezies Reaktivität: | Human |
| Immunogen: | Peptidsequenz 4-120 von humanem IDH1 |
| Konjugation: | Unconjugated |
| Alternative Synonym: | IDH1,Isocitrate dehydrogenase [NADP] (cytoplasmic),PICD,IDP,Oxalosuccinate decarboxylase,NADP(+)-specific ICDH,Cytosolic NADP-isocitrate dehydrogenase,Isocitrate Dehydrogenase 1, Soluble |
| Anti-IDH1 (Hu) aus Ratte (W09), IgG2a, Unconjugated, Monoclonal Reactivity Isocitrate dehydrogenase (IDH) is an important enzyme in the citric acid cycle and catalyzes the oxidative decarboxylation of isocitrate to alpha-ketoglutarate and CO2 while converting NAD+ to NADH. Heterozygous point mutations of IDH1 codon 132 are frequent in World Health Organization (WHO) grade II and III gliomas. IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. Mouse antibody clone H09 (product number #DIA-H09) reacts specifically with the isocitrate dehydrogenase 1 (IDH1) R132H point mutation in tissue sections from formalin-fixed brain tumor specimens. Therefore this antibody is highly useful for tumor classification. Rat antibody clone W09 detects both wild type (wt) and point mutated IDH1 in glioblastoma (anti-pan-IDH1) and serves as control for the IDH1 point mutation specific mouse antibody clone H09. Moreover, Tan et al. (Mol Cell Proteomics, 2011) have identified IDH1 as a potential diagnostic and prognostic biomarker for Non-small-cell Lung Cancer (NSCLC). These findings suggest that anti-IDH1wt antibody could be used as a histochemical biomarker for prognosis prediction of NSCLC. |
| Application Verdünnung: | Histo-/Zytochemie 1:20 - 1:100,Western Blot (WB): 1:500 |




